FOXD3 and breast carcinoma: Consistent with these results, numerous previous studies showed that the FOXD3 gene was downregulated in nasopharyngeal carcinoma [19], lung cancer [20], liver cancer [21], breast cancer [22], and colorectal cancer tissues [23].